120 related articles for article (PubMed ID: 38266355)
21. Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10.
Yuan C; Bai R; Gao Y; Jiang X; Li S; Sun W; Li Y; Huang Z; Gong Y; Xie C
Oxid Med Cell Longev; 2021; 2021():4522210. PubMed ID: 34925694
[TBL] [Abstract][Full Text] [Related]
22. CircSCUBE3 promoted ferroptosis to inhibit lung adenocarcinoma progression.
Fu H; Zhao Q
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):161-168. PubMed ID: 38430026
[TBL] [Abstract][Full Text] [Related]
23. MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.
Lu M; Hu C; Wu F; Shu L; Pan Y; Liu X; Liu P; Ma F; Deng C; Huang M
Lung Cancer; 2020 Sep; 147():193-197. PubMed ID: 32731058
[TBL] [Abstract][Full Text] [Related]
24. [TRIP13 Enhances Radioresistance of Lung Adenocarcinoma Cells
through the Homologous Recombination Pathway].
Ge S; Gu R; Yang X; Xu C; Wang S; Zhu G
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):1-12. PubMed ID: 38296621
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
[TBL] [Abstract][Full Text] [Related]
26. Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma.
Zhang Q; Shi R; Bai Y; Meng L; Hu J; Zhu H; Liu T; De X; Wang S; Wang J; Xu L; Zhou G; Yin R
Cancer Commun (Lond); 2021 Jun; 41(6):492-510. PubMed ID: 33734616
[TBL] [Abstract][Full Text] [Related]
27.
Wang Z; Zhou L; Chen B; Li X; Zou Q; Xu W; Fang L; Wu A; Li Z; Chen Y
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107669
[TBL] [Abstract][Full Text] [Related]
28. α-Hederin promotes ferroptosis and reverses cisplatin chemoresistance in non-small cell lung cancer.
Han S; Yang X; Zhuang J; Zhou Q; Wang J; Ru L; Niu F; Mao W
Aging (Albany NY); 2024 Jan; 16(2):1298-1317. PubMed ID: 38244586
[TBL] [Abstract][Full Text] [Related]
29. CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma.
Wang Z; Zhang X; Tian X; Yang Y; Ma L; Wang J; Yu Y
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846793
[TBL] [Abstract][Full Text] [Related]
30. PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.
He S; Ma X; Zheng N; Wang G; Wang M; Xia W; Yu D
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355367
[TBL] [Abstract][Full Text] [Related]
31. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
[TBL] [Abstract][Full Text] [Related]
32. New molecular insights into ferroptosis in lung adenocarcinoma progression and pharmacological compounds for targeted therapy.
Tian W; Wan X; Tian L; Wu Y; Cui X; Yi J
J Gene Med; 2024 Jan; 26(1):e3579. PubMed ID: 37581210
[TBL] [Abstract][Full Text] [Related]
33. Targeting SLC3A2 subunit of system X
Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J
Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413
[TBL] [Abstract][Full Text] [Related]
34. Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.
Lou Y; Xu J; Zhang Y; Zhang W; Zhang X; Gu P; Zhong H; Wang H; Lu J; Han B
Cell Death Dis; 2021 Feb; 12(2):170. PubMed ID: 33568630
[TBL] [Abstract][Full Text] [Related]
35. HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma.
Shi K; Li QY; Zhang YQ; Huang H; Ding DX; Luo WM; Zhang J; Guo Q
Aging (Albany NY); 2023 Oct; 15(20):11067-11091. PubMed ID: 37899135
[TBL] [Abstract][Full Text] [Related]
36. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma.
Wu X; Wang S; Chen K
Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma.
Li QY; Guo Q; Luo WM; Luo XY; Ji YM; Xu LQ; Guo JL; Shi RS; Li F; Lin CY; Zhang J; Ke D
Aging (Albany NY); 2024 Jan; 16(1):66-88. PubMed ID: 38170222
[TBL] [Abstract][Full Text] [Related]
38. DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell.
Luo J; Liu K; Yao Y; Sun Q; Zheng X; Zhu B; Zhang Q; Xu L; Shen Y; Ren B
Cancer Lett; 2019 Jul; 453():45-56. PubMed ID: 30928384
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
